Zura Bio Limited
Support and Resistance Levels
Past performance
News About ZURA
All events for ZURA
All deals for ZURA
Financial Ratios
Financial Statements
ZURA vs Sector & Peers
About Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development. Website zurabio.com
Headquarters Henderson, NV, US